BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9771441)

  • 21. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
    Nielsen JS; Sahota RA; Milne K; Kost SE; Nesslinger NJ; Watson PH; Nelson BH
    Clin Cancer Res; 2012 Jun; 18(12):3281-92. PubMed ID: 22553348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
    Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
    Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow eosinophils in plasma cell disorders.
    Wichert S; Pettersson Å; Hellmark T; Johansson Å; Hansson M
    Exp Hematol; 2018 Oct; 66():27-31.e5. PubMed ID: 29981782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas.
    Demasi AP; Magalhães MH; Furuse C; Araújo NS; Junqueira JL; Araújo VC
    Oral Dis; 2008 Nov; 14(8):741-6. PubMed ID: 18565146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD20 (pan-B cell antigen) expression on bone marrow-derived T cells.
    Algino KM; Thomason RW; King DE; Montiel MM; Craig FE
    Am J Clin Pathol; 1996 Jul; 106(1):78-81. PubMed ID: 8701937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
    Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma.
    Sahara N; Takeshita A; Shigeno K; Fujisawa S; Takeshita K; Naito K; Ihara M; Ono T; Tamashima S; Nara K; Ohnishi K; Ohno R
    Br J Haematol; 2002 Jun; 117(4):882-5. PubMed ID: 12060125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability.
    Yacyshyn B; Meddings J; Sadowski D; Bowen-Yacyshyn MB
    Dig Dis Sci; 1996 Dec; 41(12):2493-8. PubMed ID: 9011463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells.
    Hata H; Xiao H; Petrucci MT; Woodliff J; Chang R; Epstein J
    Blood; 1993 Jun; 81(12):3357-64. PubMed ID: 8507873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Instability of immunophenotype in plasma cell myeloma.
    Cao W; Goolsby CL; Nelson BP; Singhal S; Mehta J; Peterson LC
    Am J Clin Pathol; 2008 Jun; 129(6):926-33. PubMed ID: 18480010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunophenotypic characteristics of multiple myeloma cells].
    Li JL; Liu YR; Chang Y; Fu JY; Chen SS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):226-8. PubMed ID: 12513791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subsets of T lymphocytes in the lesional skin of pityriasis rosea.
    Wang S; Fu L; Du W; Hu J; Zha Y; Wang P
    An Bras Dermatol; 2019; 94(1):52-55. PubMed ID: 30726464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell antigen-positive multiple myeloma.
    Spier CM; Grogan TM; Durie BG; Richter LC; Vela E; Frutiger Y; Rangel CS
    Mod Pathol; 1990 May; 3(3):302-7. PubMed ID: 2194213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.
    Tabata R; Yasumizu R; Tabata C; Kojima M
    Pathol Res Pract; 2013 Jul; 209(7):459-62. PubMed ID: 23707547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple myeloma: 'early' plasma cell phenotype identifies patients with aggressive biological and clinical characteristics.
    Omedè P; Boccadoro M; Fusaro A; Gallone G; Pileri A
    Br J Haematol; 1993 Nov; 85(3):504-13. PubMed ID: 8136273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of CD45Ro
    Koike K; Nishiyama K; Dehari H; Ogi K; Sasaki T; Shimizu S; Sasaya T; Tsuchihashi K; Sonoda T; Hasegawa T; Hiratsuka H; Miyazaki A
    Anticancer Res; 2021 Sep; 41(9):4515-4522. PubMed ID: 34475077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of CD4 and CD45RO T cells and CD20 B cells in cerebrospinal fluid of syphilitic meningitis and tuberculous meningitis patients.
    Yu N; Zhang QQ; Zhang K; Xie Y; Zhu HQ; Lin XJ; Di Q
    APMIS; 2016 Sep; 124(9):764-9. PubMed ID: 27467195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testicular and epididymal plasmacytoma: a report of 7 cases, including three that were the initial manifestation of plasma cell myeloma.
    Ferry JA; Young RH; Scully RE
    Am J Surg Pathol; 1997 May; 21(5):590-8. PubMed ID: 9158685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.